39.41
price down icon0.44%   -0.205
 
loading
Centene Corp stock is traded at $39.41, with a volume of 728.77K. It is down -0.44% in the last 24 hours and down -15.39% over the past month. Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$39.61
Open:
$39.4
24h Volume:
728.77K
Relative Volume:
0.10
Market Cap:
$19.40B
Revenue:
$178.19B
Net Income/Loss:
$2.05B
P/E Ratio:
9.7424
EPS:
4.0447
Net Cash Flow:
$1.08B
1W Performance:
-3.72%
1M Performance:
-15.39%
6M Performance:
+56.18%
1Y Performance:
-31.29%
1-Day Range:
Value
$39.17
$40.08
1-Week Range:
Value
$36.06
$41.27
52-Week Range:
Value
$25.07
$66.03

Centene Corp Stock (CNC) Company Profile

Name
Name
Centene Corp
Name
Phone
(314) 725-4477
Name
Address
7700 FORSYTH BLVD., ST LOUIS
Name
Employee
60,500
Name
Twitter
@Centene
Name
Next Earnings Date
2025-07-25
Name
Latest SEC Filings
Name
CNC's Discussions on Twitter

Compare CNC vs UNH, CVS, CI, ELV, HUM

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Healthcare Plans icon
CNC
Centene Corp
39.45 19.48B 178.19B 2.05B 1.08B 4.0447
Healthcare Plans icon
UNH
Unitedhealth Group Inc
273.44 247.49B 447.57B 12.81B 16.08B 13.19
Healthcare Plans icon
CVS
Cvs Health Corp
75.08 96.10B 393.94B 428.00M 6.29B 0.3826
Healthcare Plans icon
CI
Cigna Group
285.38 75.83B 216.66B 6.25B 7.44B 22.19
Healthcare Plans icon
ELV
Elevance Health Inc
328.51 71.87B 199.13B 5.66B 3.17B 25.11
Healthcare Plans icon
HUM
Humana Inc
175.15 21.81B 126.36B 1.30B 1.55B 10.67

Centene Corp Stock (CNC) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-05-26 Upgrade Barclays Equal Weight → Overweight
Oct-14-25 Initiated Goldman Sell
Jul-28-25 Downgrade Cantor Fitzgerald Overweight → Neutral
Jul-23-25 Downgrade Wells Fargo Overweight → Equal Weight
Jul-21-25 Downgrade TD Cowen Buy → Hold
Jul-16-25 Downgrade BofA Securities Neutral → Underperform
Jul-10-25 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-02-25 Downgrade JP Morgan Overweight → Neutral
Jul-02-25 Downgrade UBS Buy → Neutral
Jun-09-25 Resumed Morgan Stanley Overweight
Jun-02-25 Downgrade Barclays Overweight → Equal Weight
Apr-08-25 Upgrade Jefferies Underperform → Hold
Feb-06-25 Downgrade Argus Buy → Hold
Dec-17-24 Resumed JP Morgan Overweight
Dec-13-24 Upgrade UBS Neutral → Buy
Dec-10-24 Downgrade Jefferies Hold → Underperform
Jul-24-24 Downgrade Jefferies Buy → Hold
May-30-24 Initiated Robert W. Baird Neutral
Mar-21-24 Downgrade Stephens Overweight → Equal-Weight
Mar-06-24 Initiated Barclays Overweight
Jan-02-24 Upgrade Wells Fargo Equal Weight → Overweight
Sep-05-23 Upgrade BofA Securities Underperform → Neutral
Aug-30-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-12-23 Downgrade Wolfe Research Outperform → Peer Perform
Jun-20-23 Initiated UBS Neutral
Apr-21-23 Initiated Cantor Fitzgerald Overweight
Mar-08-23 Downgrade Deutsche Bank Buy → Hold
Feb-23-23 Downgrade JP Morgan Overweight → Neutral
Dec-13-22 Downgrade BofA Securities Neutral → Underperform
Sep-30-22 Initiated Argus Buy
Aug-26-22 Downgrade Wells Fargo Overweight → Equal Weight
Jul-28-22 Resumed Barclays Overweight
Jul-14-22 Upgrade Jefferies Hold → Buy
Jun-21-22 Upgrade Credit Suisse Neutral → Outperform
Jun-17-22 Initiated Loop Capital Buy
May-27-22 Resumed Bernstein Outperform
May-26-22 Downgrade BofA Securities Buy → Neutral
Jan-07-22 Resumed Barclays Overweight
Jan-06-22 Resumed JP Morgan Overweight
Dec-14-21 Initiated Goldman Neutral
Dec-13-21 Reiterated BMO Capital Markets Outperform
Dec-13-21 Reiterated BofA Securities Buy
Dec-13-21 Reiterated Credit Suisse Neutral
Dec-13-21 Reiterated Mizuho Neutral
Dec-13-21 Reiterated Oppenheimer Outperform
Dec-13-21 Reiterated Stephens Overweight
Dec-13-21 Reiterated Truist Buy
Dec-13-21 Reiterated Wells Fargo Overweight
Dec-13-21 Reiterated Wolfe Research Outperform
Nov-01-21 Downgrade Citigroup Buy → Neutral
Sep-10-21 Initiated Cowen Outperform
Jul-09-21 Initiated Seaport Global Securities Buy
May-19-21 Initiated Wells Fargo Overweight
May-11-21 Upgrade Stephens Equal-Weight → Overweight
Mar-10-21 Initiated Mizuho Neutral
Jan-21-21 Resumed Goldman Neutral
Jan-15-21 Downgrade Jefferies Buy → Hold
Sep-22-20 Downgrade Stephens Overweight → Equal-Weight
Jul-01-20 Initiated SVB Leerink Outperform
Feb-05-20 Upgrade JP Morgan Neutral → Overweight
Feb-03-20 Resumed Evercore ISI Outperform
Jan-28-20 Reiterated Bernstein Outperform
Jan-06-20 Upgrade Wolfe Research Peer Perform → Outperform
Sep-12-19 Initiated Deutsche Bank Buy
May-10-19 Upgrade Citigroup Neutral → Buy
Jan-14-19 Initiated Stephens Overweight
Oct-24-18 Upgrade Leerink Partners Mkt Perform → Outperform
Jul-18-18 Resumed Citigroup Neutral
Dec-18-17 Reiterated Jefferies Buy
Sep-13-17 Reiterated Leerink Partners Mkt Perform
Jun-07-17 Initiated Morgan Stanley Overweight
May-22-17 Downgrade JP Morgan Overweight → Neutral
Apr-05-17 Initiated Deutsche Bank Buy
Mar-23-17 Downgrade Citigroup Buy → Neutral
Feb-08-17 Reiterated Barclays Overweight
Feb-07-17 Resumed Cantor Fitzgerald Overweight
Jan-04-17 Initiated Piper Jaffray Overweight
View All

Centene Corp Stock (CNC) Latest News

pulisher
09:50 AM

TD Cowen Issues Positive Forecast for Centene (NYSE:CNC) Stock Price - MarketBeat

09:50 AM
pulisher
08:17 AM

20 Texas Schools Partner with Superior HealthPlan and The Centene Foundation to Address Social Isolation with No One Eats Alone Initiative - Finviz

08:17 AM
pulisher
Feb 10, 2026

Morgan Stanley Maintains a Hold on Centene Corporation (CNC) - Yahoo! Finance Canada

Feb 10, 2026
pulisher
Feb 09, 2026

Centene Takes A Hit As Medicaid Membership Shrinks - AOL.com

Feb 09, 2026
pulisher
Feb 09, 2026

Centene Says Behavioral Health Accounts for Half of Excess Costs - Behavioral Health Business

Feb 09, 2026
pulisher
Feb 09, 2026

Demystifying Centene: Insights From 5 Analyst Reviews - Benzinga

Feb 09, 2026
pulisher
Feb 09, 2026

Truist Securities reiterates Buy rating on Centene stock with $47 target - Investing.com UK

Feb 09, 2026
pulisher
Feb 09, 2026

Centene (CNC) Analyst Rating Reiterated as Neutral by Cantor Fit - GuruFocus

Feb 09, 2026
pulisher
Feb 09, 2026

Cantor Fitzgerald maintains Neutral rating on Centene stock amid challenging outlook - Investing.com

Feb 09, 2026
pulisher
Feb 07, 2026

Centene’s Stock Is Down 12% in 2026: Can the 2026 Rebound Story Work? - TIKR.com

Feb 07, 2026
pulisher
Feb 07, 2026

Centene Corporation (NYSE:CNC) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 07, 2026
pulisher
Feb 06, 2026

Centene Corp (CNC) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting Sights on 2026 Growth - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Centene stock slides as 2026 profit view beats estimates but revenue forecast falls short - TechStock²

Feb 06, 2026
pulisher
Feb 06, 2026

Centene (CNC) Projects Over 40% EPS Growth for 2026 - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Centene posts $6.6B loss as health care giant grapples with rising medical costs - The Business Journals

Feb 06, 2026
pulisher
Feb 06, 2026

Centene Releases 2026 Profit Outlook Above Estimates as Shares F - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Philip Morris Beats Estimates as Smoke-Free Products Drive Earnings Momentum - Investing.com

Feb 06, 2026
pulisher
Feb 06, 2026

Centene Releases 2026 Profit Outlook Above Estimates as Shares Fall 6% - TradingView

Feb 06, 2026
pulisher
Feb 06, 2026

Earnings call transcript: Centene Corp Q4 2025 reveals EPS beat, stock drops - Investing.com

Feb 06, 2026
pulisher
Feb 06, 2026

Centene 2026 guidance slides: 40% EPS growth target despite revenue headwinds - Investing.com

Feb 06, 2026
pulisher
Feb 06, 2026

Savant Capital LLC Increases Stock Holdings in Centene Corporation $CNC - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Centene’s 2026 profit forecast tops Wall Street expectations - Modern Healthcare News

Feb 06, 2026
pulisher
Feb 06, 2026

Centene (CNC) Beats Q4 Earnings Expectations with Strong Revenue Growth - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Centene (CNC) Surpasses 2026 Profit Expectations Despite Q4 Chal - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Centene (NYSE:CNC) Surprises With Q4 CY2025 Sales - Finviz

Feb 06, 2026
pulisher
Feb 06, 2026

CENTENE CORP (NYSE:CNC) Stock Falls on Mixed 2025 Results Despite Strong 2026 Guidance - Chartmill

Feb 06, 2026
pulisher
Feb 06, 2026

Centene (CNC) Reports Q4 Loss, Beats Revenue Estimates - Yahoo! Finance Canada

Feb 06, 2026
pulisher
Feb 06, 2026

Centene: Q4 Earnings Snapshot - kens5.com

Feb 06, 2026
pulisher
Feb 06, 2026

Centene’s 2026 Profit Forecast Tops Wall Street Expectations - Bloomberg

Feb 06, 2026
pulisher
Feb 06, 2026

Centene (CNC) Projects FY26 Revenue Slightly Below Consensus - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Centene (CNC) Reports Strong Q4 Revenue Exceeding Expectations - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Centene: Fourth Quarter Earnings Overview - Bitget

Feb 06, 2026
pulisher
Feb 06, 2026

Centene shares drop nearly 3% as Q4 loss overshadows revenue beat - Investing.com

Feb 06, 2026
pulisher
Feb 06, 2026

Centene Corporation Reports 2025 Results and Announces 2026 Guidance - TradingView

Feb 06, 2026
pulisher
Feb 06, 2026

Centene’s 2026 Profit Forecast Beats Wall Street Expectations - Bloomberg

Feb 06, 2026
pulisher
Feb 06, 2026

Centene Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga

Feb 06, 2026
pulisher
Feb 05, 2026

Centene (CNC) Set to Announce Q4 Earnings with Mixed Expectations - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

Exploring Centene's Earnings Expectations - Benzinga

Feb 05, 2026
pulisher
Feb 04, 2026

Centene (CNC) Q4 Earnings: What To Expect - Finviz

Feb 04, 2026
pulisher
Feb 04, 2026

Centene Corporation (CNC): A Bull Case Theory - Finviz

Feb 04, 2026
pulisher
Feb 03, 2026

Can Centene's Q4 Earnings Escape Membership & Cost Headwinds? - Finviz

Feb 03, 2026
pulisher
Feb 03, 2026

Agree To Buy Centene At $20, Earn 6% Using Options - Nasdaq

Feb 03, 2026
pulisher
Feb 02, 2026

Top Superinvestors Are Buying Centene Corp (CNC) - The Acquirer's Multiple

Feb 02, 2026
pulisher
Feb 02, 2026

Palmetto Grain Brokerage - Palmetto Grain Brokerage

Feb 02, 2026
pulisher
Feb 02, 2026

Are Wall Street Analysts Bullish on Centene Stock? - Barchart.com

Feb 02, 2026
pulisher
Feb 02, 2026

Centene expands palliative care access in Ohio through Tuesday Health - MSN

Feb 02, 2026
pulisher
Feb 01, 2026

Retirement Systems of Alabama Has $3.55 Million Position in Centene Corporation $CNC - MarketBeat

Feb 01, 2026
pulisher
Jan 31, 2026

Mizuho Updates Centene (CNC) Valuation as Physician Survey Suggests Cooling Healthcare Utilization - Finviz

Jan 31, 2026
pulisher
Jan 31, 2026

Centene (CNC) loses 10% on flat Medicare funding - MSN

Jan 31, 2026
pulisher
Jan 30, 2026

Teacher Retirement System of Texas Has $2.33 Million Stock Position in Centene Corporation $CNC - MarketBeat

Jan 30, 2026
pulisher
Jan 29, 2026

Meridian Health Plan of Illinois and Centene Foundation Award $2.2 Million Grant to Safer Foundation for Purchase and Renovation of Affordable Housing Building in Chicago - Finviz

Jan 29, 2026

Centene Corp Stock (CNC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
healthcare_plans HUM
$175.56
price down icon 3.42%
healthcare_plans MOH
$124.07
price down icon 1.03%
$20.17
price down icon 1.95%
$13.54
price up icon 5.25%
$20.93
price down icon 2.58%
Cap:     |  Volume (24h):